Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 21, 2024; 30(27): 3326-3335
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3326
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3326
Figure 4 Box plots.
A: Hemorrhoid severity score in the endoscopic rubber band ligation (ERBL) group and the endoscopic foam sclerobanding (EFSB) group according to follow-up time. Before procedure (T0), at 8 weeks (T4), and at 12 months (T5) post-procedure. Upper and lower whiskers indicate the 75th percentile plus 1.5 interquartile range (IQR) and the 25th percentile indicates minus 1.5 IQR. Outlier: A value greater than the 75th percentile plus 1.5 IQR; B: Pain visual analogue scale score in the ERBL group and the EFSB group on follow-up at 24 hours (T1) and 1 week (T2) post-procedure. Upper and lower whiskers indicate the 75th percentile plus 1.5 IQR and the 25th percentile minus 1.5 IQR.
- Citation: Qu CY, Zhang FY, Wang W, Gao FY, Lin WL, Zhang H, Chen GY, Zhang Y, Li MM, Li ZH, Cai MH, Xu LM, Shen F. Endoscopic polidocanol foam sclerobanding for the treatment of grade II-III internal hemorrhoids: A prospective, multi-center, randomized study. World J Gastroenterol 2024; 30(27): 3326-3335
- URL: https://www.wjgnet.com/1007-9327/full/v30/i27/3326.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i27.3326